About this topic
Summary Genetic ethics is the study of the moral and political implications of (A) discoveries in the field of genetics (B) advances in genetic technology. For example, a study of the ethical, legal and social issues (ELSI) of (A) and (B) was funded as part of the Human Genome Project, started in 1986 and concluded in 2003, whose main goal was to identify all the genes in the human DNA and determine the sequence of all DNA chemical bases of a human being. Genes are units of biological hereditary information, which can be coded by different molecules (sharing similar characteristics), the most stable of which is the DNA. Since the information stored in genes influences the development of a whole organism, it is often regarded as having special importance, thus raising issues of privacy protection or discrimination. It is also apt to be used in controversial ways, e.g. deciding whether a future human person ought to exist or not (such as in selective preimplantation genetic diagnosis or abortion).  
Key works Harris 1992 argues that it is mandatory to use advances in gene therapy to remove vulnerability to infections and pollutants or to radiation damage. It advances an argument that, beside removing the genetic causes of what we regard today as "disability", it is equally mandatory to retard the ageing process, remove predispositions to heart disease, destroy carcinogens and permit human beings to tolerate other environmental pollutants.  Buchanan et al 2000 focuses on justice in the access to human genetic technology, but considers a broad range of themes and arguments: the moral heredity of eugenics, the distinction between therapy and enhancement, constrains and permissions on parental choices of genetic selection, and the disability critique of liberal eugenics. It maintains a position that is liberal, in that it permits individuals a wide range of choices concerning the genetic endowments of their future children, yet constrains it by blocking interventions which would harm the future person (by reducing future options) or society (by causing an unfair distribution of social goods). Fukuyama 2002 regards genetic technology the practice that will radically change human nature with irreversible moral implications. Genetic technology is thus objectionable, in that undermines the natural presuppositions of egalitarian liberalism. Habermas 2003 defends a principled distinction between gene-therapy to cure disease and genetic manipulation allowing parents to select the traits of future children. The latter is seen as incompatible with egalitarian relationships between human beings and their freedom of choice. 
Introductions Buchanan et al manuscript; Brock 2003.
Related

Contents
3528 found
Order:
1 — 50 / 3528
Material to categorize
  1. Value change, reprogenetic technologies, and the axiological underpinnings of reproductive choice.Jon Rueda - 2024 - Bioethics.
    Value change is a phenomenon that is gaining increasing attention in ethical analyses of technologies. However, a comprehensive study of how reprogenetic technologies and values coevolve is lacking. To remedy this gap, in this overview article, I address the relationship between reprogenetics and value change. This contribution thus argues for the importance of investigating the phenomenon of value change in relation to the technological controversies discussed in bioethics. To meet this goal, I begin by clarifying, first, how technologies shape reproductive (...)
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  2. Value change, reprogenetic technologies, and the axiological underpinnings of reproductive choice.Jon Rueda - 2024 - Bioethics.
    Value change is a phenomenon that is gaining increasing attention in ethical analyses of technologies. However, a comprehensive study of how reprogenetic technologies and values coevolve is lacking. To remedy this gap, in this overview article, I address the relationship between reprogenetics and value change. This contribution thus argues for the importance of investigating the phenomenon of value change in relation to the technological controversies discussed in bioethics. To meet this goal, I begin by clarifying, first, how technologies shape reproductive (...)
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  3. Creating future people: the ethics of genetic enhancement.Jonathan Anomaly - 2020 - New York, NY: Routledge.
    Creating Future People offers readers a fast-paced primer on how new genetic technologies will enable parents to influence the traits of their children, including their intelligence, moral capacities, physical appearances, and immune systems. It deftly explains the science of gene editing and embryo selection, and raises the central moral questions with colorful language and a brisk style. Jonathan Anomaly takes seriously the diversity of preferences parents have, and the limits policymakers face in regulating what could soon be a global market (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  4. Selected issues in biotechnology regulation: Australia, Belgium, Brazil, Canada, China, England, European Union, Germany, India, Japan, Mexico, New Zealand, Singapore, South Africa, South Korea, Taiwan.Gustavo Guerra, Kelly S. Buchanan, Louis A. Gilbert, Eduardo da Gama Soares, Tariq Ahmad, Laney Zhang, Clare Feikert-Ahalt, Jenny Gesley, Sayuri Umeda & Hanibal Goitom (eds.) - 2023 - [Washington, D.C.]: The Law Library of Congress, Global Legal Research Directorate.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  5. Creating future people: the science and ethics of genetic enhancement.Jonathan Anomaly - 2024 - New York, NY: Routledge.
    Creating Future People offers readers a fast-paced primer on how advances in genetics will enable parents to influence the traits of their children, including their children's intelligence, moral capacities, physical appearance, and immune system. It explains the science of gene editing and embryo selection, and motivates the moral questions it raises by thinking about the strategic aspects of parental choice. Professor Anomaly takes seriously the diversity of preferences parents have, and the limits policymakers face in regulating what will soon be (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  6. Should We Fear Heritable Genome Editing?Alta Charo - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  7. Heritable Genome Editing & the Problem of Progress.J. Benjamin Hurlbut - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  8. Regulating CRISPR : A Quest to Foster Safe, Ethical, and Equitable Innovation.Andrew C. Heinrich - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  9. Genome Editing, in Time.Robert Sparrow - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  10. A Therapeutic Fallacy.Peter F. R. Mills - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  11. Do Trans/Humanists Dream of Electric Tits?Florence Ashley - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  12. Curing Cystic Fibrosis?Sandra Sufian - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  13. CRISPR and Gene Editing : Why Indigenous Peoples and Why Now?Krystal Tsosie - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  14. Billie Idol.Ethan Weiss - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  15. Who Goes First?Carol Padden & Jacqueline Humphries - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  16. Welcome to the CRISPR Zoo.Marcus Schultz-Bergin - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  17. Heritable Genome Editing and International Human Rights.Kevin Doxzen & Jodi Halpern - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  18. Democratizing CRISPR : Opening the Door or Pandora's Box?Ellen Jorgensen - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  19. Untangling CRISPR's Twisted Tales.Marcy Darnovsky & Katie Hasson - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  20. CRISPR : Challenges Posed by a Dual-Use Technology.Rachel M. West & Gigi Kwik Gronvall - 2024 - In Neal Baer (ed.), The promise and peril of CRISPR. Baltimore: Johns Hopkins University Press.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  21. The promise and peril of CRISPR.Neal Baer (ed.) - 2024 - Baltimore: Johns Hopkins University Press.
    Comprising eight revised essays and seven new pieces, this work provides a comprehensive resource for students, scientists, bioethicists, physicians, and laypeople to better understand and discuss the ethical issues underlying this technology that has the potential to forever change the world.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  22. Ren lei pei tai ji yin bian ji li fa yan jiu =.Jiayou Shi - 2022 - Beijing Shi: Fa lü chu ban she. Edited by Ping Jia.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  23. Bioethics: 50 Puzzles, Problems, and Thought Experiments.Sean D. Aas, Collin O'Neil & Chiara Lepora - 2024 - New York: Routledge.
    Bioethics: 50 Puzzles, Problems, and Thought Experiments collects 50 cases—both real and imaginary—that have been, or should be, of special interest and importance to philosophical bioethics. Cases are collected together under topical headings in a natural order for an introductory course in bioethics. Each case is described in a few pages, which includes bioethical context, a concise narrative of the case itself, and a discussion of its importance, both for broader philosophical issues and for practical problems in clinical ethics and (...)
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  24. Ethical and social reflections on the proposed European Health Data Space.Ciara Staunton, Mahsa Shabani, Deborah Mascalzoni, Signe Mezinska & Santa Slokenberga - 2024 - European Journal of Human Genetics 1 (1):1-9.
    The COVID-19 pandemic demonstrated the benefits of international data sharing. Data sharing enabled the health care policy makers to make decisions based on real-time data, it enabled the tracking of the virus, and importantly it enabled the development of vaccines that were crucial to mitigating the impact of the virus. This data sharing is not the norm as data sharing needs to navigate complex ethical and legal rules, and in particular, the fragmented application of the General Data Protection Regulation (GDPR). (...)
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  25. Genética, bioética y derecho penal.José Sáez Capel - 2003 - Buenos Aires, Argentina: Proa XXI.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  26. Clonación humana y derecho.Jaime Mamani Mamani - 2003 - La Paz, Bolivia: Servicios Gráficos Illimani.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  27. Ji Yin Ji Shu Tiao Zhan Yu Fa Lü Hui Ying: Ji Yin Ke Ji Yu Fa Lü Yan Tao Hui Lun Wen Ji.Ziyi Lin & Mingcheng Cai (eds.) - 2003 - Taibei Shi: Xue lin wen hua shi ye you xian gong si.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  28. Inʼgan paea pokche ŭi pŏpchŏk yullijŏk munjechŏm kwa kŭ haegyŏl pangan.Pyŏng-gyu Chʻoe - 2003 - Sŏul Tʻŭkpyŏlsi: Chimmundang.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  29. Metodologii︠a︡ pravovogo regulirovanii︠a︡ nauki i nauchnykh issledovaniĭ: mezhdunarodnyĭ i nat︠s︡ionalʹnyĭ podkhody: monografii︠a︡.N. G. Doronina (ed.) - 2020 - Moskva: Institut zakonodatelʹstva i sravnitelʹnogo pravovedenii︠a︡ pri Pravitelʹste Rossiĭskoĭ Federat︠s︡ii.
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  30. Regulatory Environment of Cell, Tissue, and Gene Therapy Products in Singapore.Stefanie Fasshauer - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  31. The Future of Regenerative Medicine.Kristin Van Goor, Dylan Bechtle, Snehal Naik & Rasika Kalameghan - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  32. Regulation of Regenerative Medicines in Australia and New Zealand.Orin Chisholm - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  33. Cell and Gene Therapy Product Regulation in China.Yingying Liu, Linxi Wu Murphy Mao & Anette Hjelmsmark - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  34. Regulation of Regenerative Medicines in Japan.Tomoki Yokoyama & Brett Snyder - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  35. Regulation of Cell and Gene Therapies in Canada.Aileen J. Zhou - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  36. Understanding the Regulatory Framework for Regenerative Medicines in the European Union and the United Kingdom.Christiane Niederlaender - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  37. Regulation of Regenerative Medicines in the US.Stephen Westover & William Sietsema - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  38. Distribution of Regenerative Medicines.Andrea Zobel - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  39. Special Considerations for Cell-Based Advanced Therapies.Bridget Bulwer, Mo Heidaran & Darin J. Weber - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  40. Establishing Manufacturing Controls : A Hurdle for the Cell and Gene Therapy Industry.Mo Heidaran - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  41. Gene Therapy and Viral Vectors : An Overview on Current Trends.Marites T. Woon & Rajesh L. Thangapazham - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  42. Combination Products and Regenerative Medicine.Jocelyn Jennings - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  43. Special Considerations for Gene Therapy.Kristin Van Goor, Snehal Naik & Dylan Bechtle - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  44. History of Regenerative Medicine.Karen M. Hauda, Stephen Westover & Grant S. Griffin - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  45. Unique Properties of Regenerative Medicines : Key Differences From Small Molecules and Non-Regenerative Biologics.David Litwack - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  46. Introduction.Jocelyn Jennings - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
    Remove from this list  
     
    Export citation  
     
    Bookmark  
  47. GMOs and political stance: global GMO regulation, certification, labeling, and consumer preferences.Muhammad Amjad Nawaz, Gyuhwa Chung, Kirill Sergeyevich Golokhvast & Aristidis M. Tsatsakis (eds.) - 2022 - San Diego, CA, United States: Academic Press, an imprint of Elsevier.
    GMOS and Political Stance: Global GMO Regulation, Certification, Labeling, and Consumer Preferences provides a foundational-to-current challenges resource for those involved in developing and applying regulations to these important resources. Beginning with basics of GMOs, the book first familiarizes the reader with the history, economic status, associated risks, global politics, and socio-economics of GMOs. From exploring the necessity of GMO regulations with the existing GMO technology as well as new gene editing technologies to discussion by GMO regulations experts from different continents (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  48. Dürfen Gentherapien so viel kosten? – Ethische Bewertung der hohen Preise und des performanceorientierten Erstattungsmodells.Karla Alex & Julia König - 2023 - In Boris Fehse, Hannah Schickl, Sina Bartfels & Martin Zenke (eds.), Gen- und Zelltherapie 2.023 – Forschung, klinische Anwendung und Gesellschaft. Springer. pp. 317-337.
    This chapter examines whether high prices for gene therapies are justified and whether the problems associated with high prices can be solved by the "pay for performance" (P4P) reimbursement model. To this end, we first describe how prices for new drugs, including gene therapies, are set in Germany (section 2.). P4P is then presented as an example of a reimbursement model (section 3.). The subsequent ethical analysis (section 4.) first examines whether P4P models can sustainably guarantee the right to health (...)
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  49. Defusing the legal and ethical minefield of epigenetic applications in the military, defence and security context.Gratien Dalpe, Katherine Huerne, Charles Dupras, Katherine Cheung, Nicole Palmour, Eva Winkler, Karla Alex, Maxwell Mehlmann, John W. Holloway, Eline Bunnik, Harald König, Isabelle M. Mansuy, Marianne G. Rots, Cheryl Erwin, Alexandre Erler, Emanuele Libertini & Yann Joly - 2023 - Journal of Law and the Biosciences 10 (2):1-32.
    Epigenetic research has brought several important technological achievements, including identifying epigenetic clocks and signatures, and developing epigenetic editing. The potential military applications of such technologies we discuss are stratifying soldiers’ health, exposure to trauma using epigenetic testing, information about biological clocks, confirming child soldiers’ minor status using epigenetic clocks, and inducing epigenetic modifications in soldiers. These uses could become a reality. This article presents a comprehensive literature review, and analysis by interdisciplinary experts of the scientific, legal, ethical, and societal issues (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    Bookmark  
  50. Left-Libertarianism and Genetic Justice.Konstantin Morozov - 2023 - Ethical Thought 23 (1):95-108.
    Distributive justice is one of the central questions of contemporary moral and political philosophy. Discussions on this topic are often presented as a confrontation between two groups of thinkers: libertarians and luck egalitarians. The former emphasize the dependence of the existing distribution on the individual choice and personal responsibility of people, and therefore are skeptical about various redistribution programs. The latter, on the contrary, emphasize the influence of morally arbitrary luck on the economic situation of people, and therefore welcome redistributive (...)
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
1 — 50 / 3528